Sign in

CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company

Protalix BioTherapeutics, Inc.

Sign in to watch
Ticker
PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
650643773
Phone
201-696-9345
Business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Former names
ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2012-05-02 Maimon Yossi VP, Chief Financial Officer Option exercise +50,000 $2.65 $133K 125,964
2012-05-02 Maimon Yossi VP, Chief Financial Officer Sale −125,964 $7.13 $898K 0
2012-05-02 Maimon Yossi VP, Chief Financial Officer Option exercise · Stock Options (Right to Buy) −75,964 0
2012-05-02 Maimon Yossi VP, Chief Financial Officer Option exercise · Stock Options (Right to Buy) −50,000 0
2012-05-02 Aviezer David President & CEO Option exercise +326,267 $0.12 $39K 326,267
2012-05-02 Aviezer David President & CEO Option exercise +123,733 $0.97 $120K 450,000
2012-05-02 Aviezer David President & CEO Sale −450,000 $7.13 $3.2M 0
2012-05-02 Aviezer David President & CEO Option exercise · Stock Options (Right to Buy) −326,267 0
2012-05-02 Aviezer David President & CEO Option exercise · Stock Options (Right to Buy) −123,733 853,563
2012-05-02 Almon Einat Brill SVP, Product Development Option exercise +116,848 $0.97 $114K 116,848
2012-05-02 Almon Einat Brill SVP, Product Development Option exercise +50,000 $2.65 $133K 166,848
2012-05-02 Almon Einat Brill SVP, Product Development Sale −166,848 $7.13 $1.2M 0
2012-05-02 Almon Einat Brill SVP, Product Development Option exercise · Stock Options (Right to Buy) −116,848 0
2012-05-02 Almon Einat Brill SVP, Product Development Option exercise · Stock Options (Right to Buy) −50,000 0
2010-10-07 Maimon Yossi VP, Chief Financial Officer Sale −70,000 $9.67 $677K 0
2010-10-07 Maimon Yossi VP, Chief Financial Officer Option exercise +77,769 $0.97 $76K 0
2010-10-07 Maimon Yossi VP, Chief Financial Officer Shares withheld for taxes −7,769 $9.73 $76K 0
2010-10-07 Maimon Yossi VP, Chief Financial Officer Option exercise · Stock Options (Right to Buy) −77,769 75,964
2010-10-06 Almon Einat Brill VP, Product Development Sale −15,000 $9.29 $139K 0
2010-10-06 Almon Einat Brill VP, Product Development Option exercise +70,000 $0.97 $68K 0

Page 8 of 33 · 654 trades